SUBLEASESublease • July 10th, 2020 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 10th, 2020 Company IndustryThis Sublease (this “Sublease”) dated September 16, 2019 (the “Effective Date”), is made by and between Lundbeck La Jolla Research Center, Inc. (formerly known as Abide Therapeutics, Inc.), a Delaware corporation (“Sublandlord”), and Zeno Management, Inc., a Delaware corporation (“Subtenant”).
SUBLEASESublease • March 6th, 2020 • Zentalis Pharmaceuticals, LLC • Pharmaceutical preparations
Contract Type FiledMarch 6th, 2020 Company IndustryThis Sublease (this “Sublease”) dated September 16, 2019 (the “Effective Date”), is made by and between Lundbeck La Jolla Research Center, Inc. (formerly known as Abide Therapeutics, Inc.), a Delaware corporation (“Sublandlord”), and Zeno Management, Inc., a Delaware corporation (“Subtenant”).
SUBLEASESublease ( • February 14th, 2020 • Zentalis Pharmaceuticals, LLC • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2020 Company IndustryThis Sublease (this “Sublease”) dated September 16, 2019 (the “Effective Date”), is made by and between Lundbeck La Jolla Research Center, Inc. (formerly known as Abide Therapeutics, Inc.), a Delaware corporation (“Sublandlord”), and Zeno Management, Inc., a Delaware corporation (“Subtenant”).